Showing results (1-10 of 214) with videos related to
Sort By:
Pageof 22
The Journal of Biological Chemistry|February 18, 2018
Chaperone substrate provides missing link for cancer drug discoveryKatherine M Byrd, Brian S J BlaggChemmedchem|October 24, 2017
Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal InhibitorsKatherine M Byrd, Caitlin N Kent, Brian S J BlaggChemistry (Weinheim an Der Bergstrasse, Germany)|April 3, 2016
Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 InhibitorsKatherine M Byrd, Chitra Subramanian, Jacqueline Sanchez, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2022
Recent advances toward the development of Hsp90 C-terminal inhibitorsEva Amatya, Brian S J BlaggOrganic Letters|May 20, 2005
Radester, a novel inhibitor of the Hsp90 protein folding machineryGang Shen, Brian S J BlaggCurrent Medicinal Chemistry|November 11, 2008
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocketAlison Donnelly, Brian S J BlaggOrganic Letters|February 24, 2006
A versatile approach toward the ansamycin antibioticsWeimin Peng, Brian S J BlaggTetrahedron Letters|July 2, 2009
Synthesis of a versatile metacyclophane macrolactamMingwen Wang, Brian S J BlaggAdvances in Experimental Medicine and Biology|April 17, 2020
The Right Tool for the Job: An Overview of Hsp90 InhibitorsJohn Koren, Brian S J BlaggCell Stress & Chaperones|March 9, 2026
The Evolution of Hsp90 C-terminal Inhibitors: From Novobiocin to Potential Clinical CandidatesXiaosheng Jiang, Brian S J BlaggPageof 22